Combined Nanoparticle-Based Delivery of Estrogens and Raloxifen in Postmenopausal Osteoporosis. [PDF]
Włodarczyk A, Dolibog P.
europepmc +1 more source
The association between glutathione reductase and postmenopausal osteoporosis: a retrospective study. [PDF]
Wang J +13 more
europepmc +1 more source
Association between the nutritional risk index and postmenopausal osteoporosis in patients with type 2 diabetes mellitus. [PDF]
Haibier A, Lin H, Liu W, Li W.
europepmc +1 more source
A Bone-Protective Role for IFN-γ? Evidence from Genetic Association and Osteoblast Functional Assays in Postmenopausal Osteoporosis. [PDF]
de Lima CAD +8 more
europepmc +1 more source
Protein compound macrophage migration inhibitory factor for diagnosing postmenopausal osteoporosis. [PDF]
Wang C +7 more
europepmc +1 more source
Poor Knowledge and Suboptimal Practice Regarding Postmenopausal Osteoporosis Prevention Among Chinese Postmenopausal Women: A Structural Equation Model Analysis. [PDF]
Chen Y +5 more
europepmc +1 more source
Integrative Transcriptomic and Network Analysis of Shared Osteo-Immune Regulatory Programs in Postmenopausal Osteoporosis and Osteosarcoma Within Central Mexican Cohorts. [PDF]
Jiménez-Ortega RF +4 more
europepmc +1 more source
Romosozumab Versus Teriparatide for the Treatment of Postmenopausal Osteoporosis: An Overview of Systematic Reviews With Direct and Indirect Meta-Analyses. [PDF]
Bandeira TFGS +4 more
europepmc +1 more source
Osteoporosis is a metabolic bone disorder that is characterized by low bone mass and micro-architectural deterioration of bone tissue. Fractures of the proximal femur, the vertebrae and the distal radius are the most frequent osteoporotic fractures, although most fractures in the elderly are probably at least partly related to bone fragility.
Ian Reid +2 more
exaly +15 more sources

